As of December 31, 2023, GeNeuro S.A. has 24.83M shares outstanding.
| Shares Outstanding | 24.83M |
These figures are as of December 31, 2023.
| PB Ratio | -0.49 |
| P/TBV Ratio | -1.83 |
| P/FCF Ratio | -2.69 |
| P/OCF Ratio | -2.69 |
As of December 31, 2023, GeNeuro S.A. maintains a current ratio of 0.37, meaning it holds 0.4x the short-term assets needed to cover near-term liabilities.
| Current Ratio | 0.37 |
| Quick Ratio | 0.29 |
| Debt / Equity | -97.02 |
| Debt / EBITDA | -0.93 |
These figures cover the twelve months ended December 31, 2023. Return on assets (ROA) is negative at -165.51, reflecting losses generated across the asset base.
| Return on Assets (ROA) | -165.51 |
These figures cover the twelve months ended December 31, 2023. Free cash flow yield is negative at -37.13: the business is consuming cash rather than generating it, so any dividend is not covered by free cash flow. Total shareholder yield is negative at -23.19, meaning GeNeuro S.A. raised more capital through share issuance and new debt than it returned via dividends and buybacks.
| Shareholder Yield | -23.19 |
| FCF Yield | -37.13 |
As of December 31, 2023, GeNeuro S.A. has an Altman Z-Score of -24.49, below the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | -24.49 |
Already premium?